Strattera and autism

4 Its 2006 approval applied to children 5 years of age and older. Objective: The authors previously reported on a 2-by-2 randomized clinical trial of individual and combined treatment with atomoxetine (ATX) and parent training (PT) for attention-deficit/hyperactivity disorder (ADHD) symptoms and behavioral noncompliance in 128 5- to 14-year-old children with autism spectrum disorder

2024-03-28
    Enriqueta freixas vidal
  1. Strattera is longer-acting
  2. the prescriber
  3. gov means it’s official
  4. constipation *
  5. 73%
  6. Although they both treat ADHD STRATTERA gained 19